Literature DB >> 24076091

Further clinical evidence for the existence of neurotoxicity in a population of the European adder (Vipera berus berus) in eastern Hungary: second authenticated case.

Tamás Malina1, Gergely Babocsay, László Krecsák, Csaba Erdész.   

Abstract

We report a recent case of common adder (Vipera berus) envenoming causing paralytic signs and symptoms. A 12-year-old girl was bitten by the nominate subspecies of the common adder (V. berus berus) in eastern Hungary on May 2, 2012, 22 km away from where the first neurotoxic V. berus berus envenoming was reported in 2008. The patient developed unambiguous cranial nerve disturbances, manifested in bilateral impairment characterized by oculomotor paralysis with partial ptosis, gaze paresis, and diplopia. Drowsiness and photophobia were her additional symptoms; both occurred only during the first day of envenoming. Until now among viper envenomings in Europe, photophobia has only been documented by victims of Vipera aspis. Supportive and symptomatic treatments were administered during 3 days of hospitalization. Although case reports of V. berus berus envenomings are often published, clinical experience with neurotoxicity by this subspecies still remains rare. Population-based and geographic variation of venom composition in V. berus berus seems to include neurotoxic envenomings in certain populations. This second authenticated case provides new clinical evidence for the existence of a possible neurotoxic V. berus berus population in a restricted geographical area in eastern Hungary. Wilderness Medical Society.

Entities:  

Keywords:  neurotoxicity; phospholipase A(2); photophobia; ptosis; regional venom variability

Mesh:

Substances:

Year:  2013        PMID: 24076091     DOI: 10.1016/j.wem.2013.06.005

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  5 in total

1.  Diverse and Dynamic Alpha-Neurotoxicity Within Venoms from the Palearctic Viperid Snake Clade of Daboia, Macrovipera, Montivipera, and Vipera.

Authors:  Abhinandan Chowdhury; Christina N Zdenek; Bryan G Fry
Journal:  Neurotox Res       Date:  2022-10-04       Impact factor: 3.978

Review 2.  Biochemistry and toxicology of proteins and peptides purified from the venom of Vipera berus berus.

Authors:  Jüri Siigur; Ene Siigur
Journal:  Toxicon X       Date:  2022-06-12

3.  Vipera berus berus Venom from Russia: Venomics, Bioactivities and Preclinical Assessment of Microgen Antivenom.

Authors:  Ruslan I Al-Shekhadat; Ksenia S Lopushanskaya; Álvaro Segura; José María Gutiérrez; Juan J Calvete; Davinia Pla
Journal:  Toxins (Basel)       Date:  2019-02-01       Impact factor: 4.546

4.  Preclinical Assessment of a New Polyvalent Antivenom (Inoserp Europe) against Several Species of the Subfamily Viperinae.

Authors:  Alejandro García-Arredondo; Michel Martínez; Arlene Calderón; Asunción Saldívar; Raúl Soria
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

5.  Neurotoxicity and Other Clinical Manifestations of a Common European Adder (Vipera berus) Bite in Romania.

Authors:  Gabriela Viorela Nițescu; Coriolan Emil Ulmeanu; Maria-Dorina Crăciun; Alina Maria Ciucă; Alexandru Ulici; Ioan Ghira; Davide Lonati
Journal:  Toxins (Basel)       Date:  2022-07-18       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.